It has been demonstrated that NF-κB is constitutively activated in androgen-insensitive prostate carcinoma cells, and overexpression of NF-κB p65 protein was found in the nuclear fraction of prostate cancer clinical specimens [5], [9], suggesting a role for NF-κB in prostate cancer progression. The gene discussed is NFKB1; the disease is prostate cancer.